Baxter International faces Novum LVP lawsuit
Analysis based on 11 articles · First reported Oct 31, 2025 · Last updated Nov 20, 2025
The market is negatively impacted by the class action lawsuit against Baxter International, as it signals potential financial liabilities and a decline in investor confidence. This could lead to a decrease in Baxter International's stock price and potentially affect the broader medical device industry due to concerns over product safety and regulatory scrutiny.
A class action securities lawsuit has been filed against Baxter International by Levi & Korsinsky on behalf of investors who suffered losses between February 23, 2022, and July 30, 2025. The lawsuit alleges that Baxter International made false statements and concealed systemic defects in its Novum LVP product, which caused malfunctions, injuries, and deaths. The complaint claims that Baxter International's attempts to address these defects were inadequate, leading to a heightened risk of product removal from service and a pause in new sales. Investors have until December 15, 2025, to request to be appointed as lead plaintiff.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard